Skip to main content

Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back

Objective

Coping with breast cancer more and more becomes a major socio-economic challenge not least due to its constantly increasing incidence in the developing world. There is a growing need for novel strategies to improve understanding and capacity to predict resilience of women to the variety of stressful experiences and practical challenges related to breast cancer. This is a necessary step toward efficient recovery through personalized interventions. BOUNCE will bring together modeling, medical, and social sciences experts to advance current knowledge on the dynamic nature of resilience as it relates to efficient recovery from breast cancer. BOUNCE will take into consideration clinical, cancer-related biological, lifestyle, and psychosocial parameters in order to predict individual resilience trajectories throughout the cancer continuum and eventually increase resilience in breast cancer survivors and help them remain in the workforce and enjoy a better quality of life.
BOUNCE will deliver a unified clinical model of modifiable factors associated with optimal disease outcomes and will deploy a prospective multi-center clinical pilot at four major oncology centers (in Italy, Finland, Israel and Portugal), where a total of 660 women will be recruited in order to assess its clinical validity against crucial patient outcomes (illness progression, wellbeing, and functionality). The advanced computational tools to be employed will validate indices of patients’ capacity to bounce back during the highly stressful treatment and recovery period following diagnosis of breast cancer. The overreaching goal of BOUNCE is to incorporate elements of a dynamic, predictive model of patient outcomes in building a decision-support system used in routine clinical practice to provide physicians and other health professionals with concrete, personalized recommendations regarding optimal psychosocial support strategies.

Field of science

  • /medical and health sciences/clinical medicine/cancer/breast cancer

Call for proposal

H2020-SC1-2017-CNECT-2
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ
Address
Stenbackinkatu 9
00029 Helsinki
Finland
Activity type
Research Organisations
EU contribution
€ 795 625

Participants (8)

IDRYMA TECHNOLOGIAS KAI EREVNAS
Greece
EU contribution
€ 726 875
Address
N Plastira Str 100
70013 Irakleio
Activity type
Research Organisations
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Italy
EU contribution
€ 375 600
Address
Via Filodrammatici 10
20121 Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS
Greece
EU contribution
€ 487 500
Address
Patission Str. 42
10682 Athina
Activity type
Research Organisations
NHG FINLAND OY
Finland
EU contribution
€ 747 435
Address
Vattuniemenranta 2
00210 Helsinki
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
THE HEBREW UNIVERSITY OF JERUSALEM
Israel
EU contribution
€ 557 000
Address
Edmond J Safra Campus Givat Ram
91904 Jerusalem
Activity type
Higher or Secondary Education Establishments
SINGULARLOGIC ANONYMI ETAIREIA PLIROFORIAKON SYSTIMATON KAI EFARMOGONPLIROFORIKIS
Greece
EU contribution
€ 448 125
Address
Achaias 3 & Troizinias
14564 Nea Kifisia
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD
Portugal
EU contribution
€ 497 000
Address
Avenida Brasilia, Centro De Investigacao Da Fundacao Champalimaud
1400-038 Lisboa
Activity type
Research Organisations
NOONA HEALTHCARE OY
Finland
EU contribution
€ 364 250
Address
Tehtaankatu 27-29 A
00150 Helsinki
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)